Your Best Stock
Stocks › Biotechnology › REGN

Regeneron Pharmaceuticals REGN

US equityMarket cap rank #196BiotechnologyInfectious Disease
$794.67
−$7.16 (-0.89%)
Market open · Sep 24, 2:00 pm ET
After hours $801.82 0.00%
Open$801.59
Prev close$801.82
Day range$789.41 – $807.21
Volume268.3K
Market cap$81.81B
P/E (TTM)19.7
Dividend yield0.46%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership94.1%+0.35 pts vs. prior quarter
Institutions holding1,663-11 vs. prior quarter
Insider trades (recent)2 buys / 6 sellsNet selling
Short interest2.48% of floatDays to cover 3.9 · as of 31 Aug 2026
Short-sale volume share12.7%5-day average of daily volume

Short-sale volume as % of daily volume

8%12%16%20%Aug '26Sep '26Sep '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$8.49M (10 inflow days, 10 outflow days).

Largest holders

  • BlackRock9.13%
  • Vanguard Capital Management, LLC7.20%
  • Dodge & Cox4.88%
  • State Street Global Advisors4.84%
  • Invesco Capital Management LLC3.24%

By investor type

  • Mutual Fund78.73%
  • Hedge Fund4.61%
  • Public Company4.12%
  • Individual/Insider3.83%
  • Government Pension Fund2.53%
  • Private Company1.87%
  • Sovereign Wealth Fund1.27%
  • Insurance Company0.41%
Institutional holders1,663
Institutional ownership94.1%

Insider activity

Total transactions21
Bought2
Sold6

Short interest

Report dateShares short% of floatDays to cover
31 Aug 2026 2,552,029 2.5% 3.9
14 Aug 2026 2,396,152 2.3% 3.2
31 Jul 2026 3,385,841 3.3% 3.9
15 Jul 2026 3,501,203 3.3% 4.7
30 Jun 2026 3,494,420 3.3% 2.9
15 Jun 2026 3,304,329 3.2% 3.4
Scroll to Top